TipRanks
3 monster growth stocks that could reach new highs
Investors have a clear task ahead: find the stocks that will rise with an approaching bull market. Past performance is, of course, no guarantee of future gains, but the stocks that have grown rapidly in recent months are a logical place to start looking for tomorrow’s winners. There are, of course, concerns directed at the newly Democratic U.S. Senate that will give the incoming Biden government the chance to implement its tax increase plan, and the weak number of jobs in December; will they pull together to derail the strong upward trend of the market, according to Jonathan Golub of Credit Suisse not so fast? The U.S. chief equity strategist raised his outlook for year-end 2021 to 4,050 to 4,200. Golub points out that the Democratic candidates both got the Senate opportunity in Georgia in the recent vote, a development that effectively controls the Control – albeit at the smallest possible margins – of both Houses of Congress. The incoming Biden administration has committed itself to signing a larger COVID relief package and to reversing President Trump’s policies. Control of Congress is a necessary condition. Golub said: “This should result in additional incentives, including extending payments to individuals.” The second point that Golub notes as a major supporting event for the markets is the COVID vaccination program. Describing the slow progress of the program as ‘overwhelming’, he adds that as the vaccinated population grows, economic activity will expand. According to Golub, the main economic effect of the closure policy is a likely avalanche of pent-up consumer demand [which] can not be ignored. Golub says about the question and says: “We are going to have the biggest stimulating event in the history of the planet in the second half of this year …” The strategist now sees it – before the takeoff of the second half – as the to buy in. And that brings us back to growth stocks. According to the analyst community, we used the TipRanks database to identify three exciting growth names. Every director backed by analysts could rise even higher than the already impressive growth. Innovative Industrial Properties (IIPR) The growing normalization of the marijuana industry in the US has opened up a range of opportunities for future businesses. Innovative industrial properties are one of them. This company is a solid investment trust with a twist – it focuses on properties in the cannabis sector for medical use. IIPR acquires, owns, manages and leases properties like most REITs, but its customer base consists of experiences, say licensed, medical cannabis operators. The company’s portfolio consists of industrial greenhouses that are leased as medical facilities to medical cannabis suppliers. The value of this niche is evident from the inventory performance. IIPR shares have risen 137% over the past 52 weeks. Financial performance is consistent with equity performance; Revenue has risen steadily quarter on quarter over the past two years, and in the third quarter of the twentieth quarter, $ 34.33 million. That was a profit of 197% year-on-year. In the first quarter and second quarter of 2020, there was a slight decline in corona panic, but the quarter of the third quarter of the year turned it around and the pressure of 86 percent was 59% per year. Daniel Santos, analyst at Piper Sandler, sees the momentum building. the cannabis industry, especially now that the Senate has switched to democratic control. “COVID has created its own headwind while states are running to fill budget gaps with alternative tax sources. While this may lead to a more liberal licensing, management has seemed that most states will choose a limited licensing program and benefit existing entrepreneurs – a major boost for IIPR. Santos rates IIPR as overweight (ie buy), and its $ 250 price target implies a 40% increase for the next 12 months. (Click here to see Santos’ record) Overall, IIPR has 7 recent reviews on record, broken down to 5 Buys and 2 Holds, giving the stock a consensus rating from Moderate Buy analysts. Shares have risen rapidly recently and are now trading at $ 178.44. Par Technology provides support in the hospitality industry by providing software, hardware, support services and other resources. PAR applications include point-of-sale software, content management, business intelligence, food monitoring, sales terminals and video monitors. The restaurant segment of PAR boasts operations in 110 countries, with more than 100,000 user installations. The company also includes a government services segment, which provides computer-based engineering services and systems design to the Federal Government. PAR is a major contractor of such services at the Department of Defense, and the growth of this company has been impressive over the past year. The 52-week gain is 103%, reflecting the need for strong online support for PAR’s target customer base as it works to recover from the COVID downturn. Revenue from the third quarter of 2020 recovered from a modest decline in the first half of the year, reaching a two-year high of $ 54.8 million. Among the supporters is BTIG analyst Mark Palmer, who wrote: ‘While we expect PAR’s restaurant and retail revenues to grow by around 20% over the next three years, we expect its Brink software industry to grow annually. growth in the 40% context during this period … As PAR performs after the transition to a cloud software / SaaS mode, its valuation needs to grow due to the recurring nature of its subscription revenue and the margins associated with the software offering better to reflect. Consistent with his comments, the 5-star analyst rates PAR a Buy along with a price target of $ 80. This figure indicates his confidence in an upward return of 29% for one year. (Click here to see Palmer’s record.) PAR has strong support from the rest of the street. Except for a single Hold, all 4 other analysts who have published a review over the past three months recommend PAR shares as a buy. (See PAR stock analysis on TipRanks) Maxlinear, Inc. (MXL) The semiconductor sector is a major industry and Maxlinear manufactures chips for various roles: wireless and data center infrastructure, industrial connectivity and IoT applications, cable broadband and WiFi 6 network. Maxlinear’s products are found in digital TVs, mobile devices, computers and netbooks. Semiconductors have torn over the past few months and MXL stock is no exception. The stock has risen 81% since January last year, and the period includes sharp losses in February and March. The shift to remote work and virtual schools has placed a premium on fast and reliable connections, which in turn has increased demand for the underlying chips. In 3Q20, Maxlinear’s top line rose to $ 156 million, a successive profit of 140% and a year-on-year profit of 95%. The company recognizes the greater demand for broadband and connectivity products starting from 2Q20, as the driving force for profit. Suji DeSilva, 5-star analyst at Roth Capital, is strong on this stock and his comments make it clear. “We believe that MXL is a differentiated investment opportunity in broadband and network RF and mixed signal opportunities. We believe MXL is seeing a continued strongly linked demand for homes being increased through continued remote work. We expect the basic principles of MXL to benefit from the acquisition in CY21, ”says DeSilva. DeSilva sets a price target of $ 50 and a buy rating on MXL shares. Its target indicates a one-year lead of 34%. (To see DeSilva’s record, click here. All in all, the word on the street is mostly positive on this chipmaker, with TipRanks analysis showing MXL as a moderate buy. The stock has 7 reviews on record, with a split from 5 to 2 between Buys and Holds. (See MXL stock analysis on TipRanks) Visit TipRanks ‘best-selling stocks, a newly introduced tool that unites all of TipRanks’ equity insights. Only those of the proposed analysts. The content is for informational purposes only.It is very important to do your own analysis before investing.